Brugman Frans, Veldink Jan H, Franssen Hessel, de Visser Marianne, de Jong J M B Vianney, Faber Carin G, Kremer Berry H P, Schelhaas H Jurgen, van Doorn Pieter A, Verschuuren Jan J G M, Bruyn Richard P M, Kuks Jan B M, Robberecht Wim, Wokke John H J, van den Berg Leonard H
Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.
Arch Neurol. 2009 Apr;66(4):509-14. doi: 10.1001/archneurol.2009.19.
To study whether clinical characteristics can differentiate sporadic presentations of hereditary spastic paraparesis (HSP) from primary lateral sclerosis (PLS). Differentiation between these diseases is important for genetic counseling and prognostication.
Case series.
Tertiary referral center.
One hundred four Dutch patients with an adult-onset, sporadic upper motor neuron syndrome of at least 3 years' duration. Hereditary spastic paraparesis was genetically confirmed in 14 patients (7 with SPG4 and 7 with SPG7 mutations).
All 14 patients with the SPG4 or SPG7 mutation had symptom onset in the legs, and 1 of the patients with the SPG7 mutation also developed symptoms in the arms. Of the other 90 patients, 78 (87%) had symptom onset in the legs. Thirty-six patients developed a PLS phenotype (bulbar region involvement), 15 had a phenotype that was difficult to classify as similar to HSP or PLS (involvement of legs and arms only), and 39 continued to have a phenotype similar to typical HSP (involvement of the legs only). Median age at onset was lower in patients with the SPG4 or SPG7 mutation (39 [range, 29-69] years), but there was considerable overlap with patients with the PLS phenotype (52 [range, 32-76] years). No differences were found in the features used by previous studies to distinguish HSP from PLS, including evidence of mild dorsal column impairment (decreased vibratory sense or abnormal leg somatosensory evoked potentials), symptoms of urinary urgency, or mild electromyographic abnormalities.
In most patients with a sporadic adult-onset upper motor neuron syndrome, differentiation of sporadic presentations of HSP from PLS based on clinical characteristics is unreliable and therefore depends on results of genetic testing.
研究临床特征能否区分遗传性痉挛性截瘫(HSP)的散发性表现与原发性侧索硬化症(PLS)。区分这些疾病对于遗传咨询和预后判断很重要。
病例系列研究。
三级转诊中心。
104例成年起病、散发性上运动神经元综合征且病程至少3年的荷兰患者。14例患者经基因确诊为遗传性痉挛性截瘫(7例携带SPG4突变,7例携带SPG7突变)。
所有14例携带SPG4或SPG7突变的患者均以腿部症状起病,1例携带SPG7突变的患者上肢也出现了症状。在其他90例患者中,78例(87%)以腿部症状起病。36例患者出现了PLS表型(累及延髓区域),15例患者的表型难以归类为类似HSP或PLS(仅累及腿部和上肢),39例患者继续表现为类似典型HSP的表型(仅累及腿部)。携带SPG4或SPG7突变的患者发病时的中位年龄较低(39岁[范围29 - 69岁]),但与PLS表型的患者有相当大的重叠(52岁[范围32 - 76岁])。在先前研究用于区分HSP与PLS的特征方面未发现差异,包括轻度后索损害的证据(振动觉减退或腿部体感诱发电位异常)、尿急症状或轻度肌电图异常。
在大多数成年起病的散发性上运动神经元综合征患者中,基于临床特征区分HSP的散发性表现与PLS是不可靠的,因此依赖于基因检测结果。